, Singapore

Daily Markets Briefing: STI up 0.4%

Here's the next obstacle.

According to OCBC, the recovery on Wall Street overnight is likely to keep local sentiments fairly buoyant this morning.

Here's more from OCBC:

Following yesterday’s 0.4% gains, we could potentially see the STI maintaining its run and test the 3310 key resistance today.

Technically, the daily MACD has already initiated a bullish crossover; this suggests an improving upside momentum.

Beyond the 3310 hurdle, we see the next obstacle at the 3360-3370 gap resistance. On the downside, 3260 (minor trough and uptrend support) is the immediate support, followed by the next base at the 3240 trough.
 

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

If you've been wondering whether SBR could work for your company — yes, probably.

A lot of the companies we partner with started as readers. They'd been following our coverage for a while, saw their own customers and competitors in it, and eventually asked the obvious question: could we do something with you? The answer is usually yes. The shape of it depends on what you're trying to do.


The options are broader than most people assume — thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. Some partners use one channel; most use a mix. We figure out the right combination by starting with your brief, not with our rate card.


So if the question has been on your mind, here's the easy way to ask it.

We'll tell you honestly whether we can help, and how. It's a better use of everyone's time.

Top News

7 in 10 unprepared for AI-driven cyberattacks
Only 38% said their organisation provided training on how to use AI whilst avoiding exploitation.
CCS overhauls passenger airline alliance framework
Airline alliance notifications are now streamlined into a three-step approach.
Aviation
Raffles Medical net profit falls 9.6% to $29m in H1
Its healthcare services division posted a 16% drop in revenue to $119.5m.
Healthcare